SCHEMBL1100772

SCHEMBL1100772

CC(C)c1c(N(CCC2CC2)S(=O)(=O)c2ccccc2)sc2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 3/20 0.36
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 2/20 0.35
ALDH1A1 P00352 1/20 0.34
KEAP1 Q14145 2/20 0.33
NFE2L2 Q16236 2/20 0.33
GBA1 P04062 1/20 0.33
NR1I2 O75469 1/20 0.33
HTR2A P28223 4/20 0.33
BACE1 P56817 1/20 0.33
HTR2C P28335 1/20 0.33
HTR1A P08908 3/20 0.33
DRD2 P14416 3/20 0.33
DRD3 P35462 1/20 0.33
HTR7 P34969 2/20 0.32
HSD11B1 P28845 1/20 0.32
HTR6 P50406 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1097808 0.91 TRPM8 (0.47) TRPM8
SCHEMBL1097429 0.87 TRPM8 (0.42) TRPM8KDM4EMEN1KMT2AALDH1A1
SCHEMBL1098232 0.85 TRPM8 (0.48) TRPM8KDM4EMEN1KMT2ALMNA
SCHEMBL1099694 0.83 KDM4E (0.37) TRPM8KDM4EMEN1KMT2ALMNA
SCHEMBL1099265 0.77 TRPM8 (0.61) TRPM8
SCHEMBL1099089 0.77 TRPM8 (0.44) TRPM8MEN1KMT2ALMNAKEAP1
SCHEMBL1099266 0.75 TRPM8 (0.36) TRPM8KMT2AALDH1A1KEAP1NFE2L2
SCHEMBL1100475 0.75 TRPM8 (0.47) TRPM8MEN1KMT2A
SCHEMBL1099915 0.75 TRPM8 (0.43) TRPM8
SCHEMBL1101372 0.75 TRPM8 (0.49) TRPM8MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9434711-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, N.V. (BE) 2016-09-06 US disclosed
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2014-10-23 US disclosed
CN-101801949-B Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA NV 2014-09-24 CN disclosed
US-8809327-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2014-08-19 US disclosed
EP-2183239-B1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2012-08-22 EP disclosed
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS BRANUM SHAWN T (US) 2012-07-26 US disclosed
US-8153682-B2 Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA, NV (BE) 2012-04-10 US disclosed
CN-101801949-A Sulfonamides as TRPM8 modulators JANSSEN PHARMACEUTICA NV 2010-08-11 CN disclosed
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS JANSSEN PHARMACEUTICA, N.V. (BE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190674-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885KDM4E 3266/4885MEN1 1640/4885
US-20140315899-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885KDM4E 3266/4885MEN1 1640/4885
US-20090264474-A1 SULFONAMIDES AS TRPM8 MODULATORS TRPM8, TRPM5, TRPM2 TRPM8 1/4885KDM4E 3266/4885MEN1 1640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.